Anúncios
relacionados a: nccn colorectal cancerLearn About Clinical Trials for Colorectal Cancer With the MSI-H Biomarker. Find Resources Here.
- Dosing and Administration
Get Dosing Information for Patients
With Advanced MSI-H/dMMR CRC.
- Clinical Data
View Clinical Data for Patients
With Advanced MSI-H/dMMR CRC.
- Ask Merck
Connect With a Merck Associate Now
or Schedule a Call.
- Safety Information
See Safety Information for Patients
With Advanced MSI-H/dMMR CRC.
- Dosing and Administration
Leading to Faster Responses, Better Outcomes, Fewer Side Effects & More Hope. Designing the Best Treatment Plan & Therapies to Target Your Specific Cancer.
543 Taylor Ave, Columbus, Ohio · Itinerário · (614) 293-2225
HCPs: New Treatment For Metastatic Solid Tumors Including Colorectal Cancer. View Data. Physicians: Identify Patients For A Solid Tumor Therapy In Metastatic Colorectal Cancer.
Resultado da Busca
any clinician seeking to apply or consult the nccn content, the nccn guidelines and/or any derivative resources is expected to use independent medical judgment in the context of the individual clinical circumstances to determine any patient's care or treatment.
2 de mar. de 2021 · This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section.
- Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi Jen Chen, Kristen K. Ciombo...
- 2021
Fight Colorectal Cancer (Fight CRC) is a leading patient-empowerment and advocacy organization providing balanced and objective information on colon and rectal cancer research, treatment, and policy.
- 7MB
- 74
The complete version of the NCCN Guidelines for Rectal Cancer, available online at NCCN.org, covers additional topics including risk assessment, pathology and staging, management of metastatic disease, posttreatment surveillance, treatment of recurrent disease, and survivorship.
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. In 2016, an estimated 95,270 new cases of colon cancer and approximately 39,220 cases of rectal cancer will occur.
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship.
